ZakhariaYousef Profile Banner
Yousef Zakharia Profile
Yousef Zakharia

@ZakhariaYousef

Followers
1K
Following
3K
Media
124
Statuses
1K

Professor of Medicine, Genitourinary Malignancy Medical Oncologist, Experimental Therapeutics, Mayo Clinic Comprehensive Cancer Center.

United States
Joined April 2017
Don't wanna be here? Send us removal request.
@ZakhariaYousef
Yousef Zakharia
2 years
Very honored and humbled by ⁦@kidneycan⁩ spotlight, a great community to be part of. ⁦⁦⁦@UIowaCancer⁩ ⁦@uihealthcare⁩ ⁦@IntMedatIowa⁩ ⁦@IowaMed⁩ ⁦@UIowa_urology�� Dr. Yousef Zakharia | KidneyCAN Community Spotlight
Tweet card summary image
kidneycan.org
Dr. Yousef Nabih Zakharia's journey from Syria to the heart of Iowa, his dedication to his patients, and his unwavering commitment to advancing kidney cancer research is truly inspiring.
8
9
93
@jitcancer
Journal for ImmunoTherapy of Cancer
2 days
New #JITC article: Genetic haplotypes in VWA8, OSBPL6, and ADAMTS9-AS2 are associated with immune-related adverse effects in ICI-treated patients with cancer https://t.co/XjHZGBtwEs @ZakhariaYousef @PuzanovIgor
0
2
5
@Parminder1699
Parminder singh
3 days
Real-World Outcomes of Enfortumab Vedotin and Pembrolizumab in Advanced Urothelial Carcinoma: A Multicenter Retrospective Analysis -sharing Mayo Clinic experience with EV Pembro , consistent with phase III trial,also in patients on dialysis
0
4
16
@chadinabhan
chadi nabhan MD, MBA, FACP
3 days
You know it - will be watching & listening to this one as @GIcancerDoc of @MayoClinic and others share their views and opinions on cancer care. 👇👇👇
@LBCILebanon
LBCI TV
3 days
يستضيف الإعلامي ألبير كوستانيان في حلقة الليلة من #عشرين_30: وزير الصحة د. ركان ناصر الدين، ومدير ومؤسس مركز ترشيد السياسات والمدير التنفيذي لمنصة المشورة للجهات الحكومية في الجامعة الأميركية في بيروت الدكتور فادي الجردلي، ورئيس قسم أمراض الدم والأورام في Mayo Clinic بأريزونا،
1
2
6
@ZakhariaYousef
Yousef Zakharia
19 days
Another success story for EV pembro in cis ineligible MIBC!! multi-ovations in one presentation!!
0
2
3
@KidneyCancer
Kidney Cancer
1 month
🎉 Congratulations @MichaelASJewett, recipient of KCA's Nicholas J. Vogelzang Humanitarian Award at #IKCSNA25! Proud to award this recognition of outstanding service and compassion in #kidneycancer care. Read more: https://t.co/ud1wtMFOZB
2
12
33
@KidneyCancer
Kidney Cancer
1 month
🎉 Congratulations @ejasonabel who will receive the KCA's Andrew C. Novick Award at #IKCSNA25! This award recognizes excellence in #kidneycancer urology care. Read more: https://t.co/ud1wtMFOZB
0
14
34
@KidneyCancer
Kidney Cancer
1 month
🎉 Congratulations @AChakrabortyPhD who will receive the KCA's Christopher G. Wood Rising Star Award at #IKCSNA25! This award recognizes talented and promising #kidneycancer experts. Read more: https://t.co/ud1wtMFOZB
1
10
30
@ZakhariaYousef
Yousef Zakharia
2 months
Was great chatting with @Raquib_Hannan and @ChadTangMD about the role of RT in RCC through @oncodaily #GlobalVoicesInRenalOncology An effective tool to be utilized in clinic @KidneyCancer @kidneycan @MayoCancerCare @DrYukselUrun @CParkMD @IrbazRiaz Thx for summarizing @mehndz
@mehndz
Mehndi Dandwani
2 months
@oncodaily #GlobalVoicesInR enalOncology Size doesn’t matter as much as location for SBRT @ChadTangMD @ZakhariaYousef ⭕️Radiation stimulates Ag presentation ⭕️Fractionated approach favored >8cm ⭕️10-15 ml/min decline in eGFR ⭕️TKIs with radiation, hold at least for 2.5 t1/2
1
6
23
@IrbazRiaz
Irbaz Riaz MD,MS,MBI,PhD
2 months
What a privilege to host @anantm at our #AI lab @MayoCancerCare.His stories and life lessons left our trainees inspired. Moments like these remind us why mentorship matters. Deeply grateful for his time and wisdom #Mentorship #Inspiration
6
13
50
@DrYukselUrun
Yüksel Ürün
2 months
Global voices, shared hope. Excited to join colleagues at VIRO 2025, working together for patients in renal cancer. Please join us: Free Registration link: https://t.co/5mIBcWKg09 #OncoDaily #VIRO2025 @oncodaily
0
9
26
@kais_zakharia
Kais Zakharia, MD
2 months
Grateful to @VideoGIE for featuring our work at @Baystate_Health 🙏 We managed a 14 cm Barrett’s esophagus with multifocal adenocarcinoma using circumferential ESD—final specimen length: 16 cm. Honored to see it on the cover of VideoGIE! @BaystateAdvEndo @Aida_Saad97
@videogie
VideoGIE Journal
2 months
Aida Saad, MD, et al detail the case of a patient with an ultralong segment of Barrett’s esophagus and multifocal esophageal adenocarcinoma successfully treated with circumferential endoscopic submucosal dissection. https://t.co/3EUV0ZW02h #GITwitter @Aida_saad97
1
3
8
@oncodaily
OncoDaily
2 months
🌍 𝗚𝗹𝗼𝗯𝗮𝗹 𝗩𝗼𝗶𝗰𝗲𝘀 𝗶𝗻 𝗥𝗲𝗻𝗮𝗹 𝗢𝗻𝗰𝗼𝗹𝗼𝗴𝘆 (𝗩𝗜𝗥𝗢) 𝗩𝗶𝗿𝘁𝘂𝗮𝗹 𝗖𝗼𝗻𝗴𝗿𝗲𝘀𝘀 📅 Sept 11–12, 2025 | 🩺 Chaired by Dr. Rana McKay (@DrRanaMcKay) & co-chaired by Dr. Yüksel Ürün (@DrYukselUrun ) 🔗 𝗥𝗲𝗴𝗶𝘀𝘁𝗲𝗿 𝗳𝗼𝗿 𝗳𝗿𝗲𝗲:
1
2
13
@KainatWarraich6
Kainat Warraich
3 months
Honored to present my poster today at the iconic Country Music Hall of Fame and Museum in Nashville @GUconference Deeply grateful to @ZakhariaYousef @h_abdulmuhsin and @IrbazRiaz for their mentorship and to @CCF_IMCHIEFS for their support in making this presentation possible!
21
8
161
@crisbergerot
Cristiane D Bergerot, PhD, FASCO
3 months
Excited to share our new paper @EurUrolOncol! 🎉 We developed patient-centered, stage-specific FKSI-23 tools to better capture HRQOL in localized & metastatic RCC, moving beyond generic instruments to what truly matters to patients @tompowles1 @montypal https://t.co/2sTCZRdIjH
9
37
129
@ZakhariaYousef
Yousef Zakharia
3 months
2 of my favorite urologists and a lot of bladder expertise in one shot!!
@urotoday
UroToday.com
3 months
Optimizing TURBT: Balancing surgical skill and advanced technology. @MarkTysonMD @MayoClinic & @VigneshPackiam @RutgersCancer sit down with @UroDocAsh @MDAndersonNews covering practical considerations including catheter management, environmental sustainability, patient-friendly
0
1
6
@KidneyCancer
Kidney Cancer
3 months
Register NOW for discounted rates to 2025 IKCS: North America! #IKCSNA25 🔗 https://t.co/48Xa9jZxCI We welcome you to join us in pushing the boundaries of #kidneycancer research and patient care. Early bird rates available through Oct 16. See you in the Rockies!
1
7
16
@KidneyCancer
Kidney Cancer
4 months
🎊 Abstract Submissions for #IKCSNA25 are Open! 🎊 Join the KCA on Nov 13-15 in Denver, CO for the 2025 IKCS: North America. Gather with top #kidneycancer experts to discuss and advance the field! But first! Submit your abstracts and register: https://t.co/BtpJZidr6L
0
7
17
@OncLive
OncLive.com
3 months
Tanios S. Bekaii-Saab, MD, (@GIcancerDoc) of @MayoCancerCare discusses sequencing approaches in metastatic pancreatic cancer and colorectal cancer. Read more here: https://t.co/nfIJJQCjqH
0
2
6
@ZakhariaYousef
Yousef Zakharia
3 months
Good molecule
@OncoAlert
OncoAlert
3 months
Intratumoral vidutolimod as monotherapy or in combination with pembrolizumab in patients with programmed cell death 1 blockade–resistant #melanoma : Final analysis from a phase 1b study https://t.co/NPlPt8csFL This final analysis of a phase 1b, open-label, multicenter study
0
2
7
@drulkav
Ulka Vaishampayan
3 months
Honored to co chair a clinical trials session at IKCS25 looking forward to the sessions education and research blend with latest and greatest I. Kidney cancer
@ZakhariaYousef
Yousef Zakharia
3 months
Honored to co-chair IKCS25 in Denver CO with @spsutkaMD @mkbupathi , abst deadline Aug15, great agenda put together with @QingZhangLab @bergsa83 @ChadTangMD #MCarlo #DGeynisman @salvolarosa @KidneyCancer plz submit abst
1
4
13